Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.37 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.37 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29218960 | 0.93 | GPR84 (0.42) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL31212517 | 0.93 | GPR84 (0.42) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL9955355 | 0.90 | GPR84 (0.42) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL5683420 | 0.90 | GPR84 (0.42) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL9954679 | 0.90 | GPR84 (0.42) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL342996 | 0.89 | GPR84 (0.43) | GPR84FFAR1PPARD | |
| SCHEMBL17688068 | 0.89 | GPR84 (0.43) | GPR84FFAR1PPARD | |
| SCHEMBL141909 | 0.88 | GPR84 (0.39) | GPR84FFAR1MAPTLCKPPARD | |
| Glycerin SCHEMBL28490549 | 0.86 | GPR84 (0.41) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL11596358 | 0.86 | FFAR4 (0.51) | GPR84FFAR1MAPTPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3784706-B1 | PREPARATION OF AN ACTIVE POLYMER EMULSION | COATEX SAS (FR) | 2024-04-03 | — | — | EP | claimed |
| EP-2804670-B1 | COSMETIC COMPOSITION COMPRISING ENCAPSULATED PIGMENTS AND REFLECTIVE PARTICLES PREDISPERSED IN AN OIL | OREAL (FR) | 2017-06-14 | — | — | EP | claimed |
| EP-1834628-B1 | Cosmetic composition comprising phytosterols, isoflavones and methylricinoleate, use as inhibitor of 5-alpha-reductase and hair growth | FIRST S P A (IT) | 2010-12-29 | — | — | EP | claimed |
| CN-107530256-B | Topical sunscreen emulsions | 帝斯曼知识产权资产管理有限公司 | 2021-02-02 | — | — | CN | disclosed |
| US-20140350269-A1 | Acetals Esters Produced from Purified Glycerin for Use and Application as Emollients, Lubricants, Plasticizers, Solvents, Coalescents, Humectant, Polymerization Monomers, Additives to Biofuels | GLYCEROSOLUTION QUÍMICA LTDA. (BR) | 2014-11-27 | — | — | US | disclosed |
| EP-2799433-A2 | Acetals esters produced from purified glycerin for use and application as emollients, lubricants, plasticizers, solvents, coalescents, humectant, polymerization monomers, additives to biofuels | Glycerosolution Quimica, Ltda (BR) | 2014-11-05 | — | — | EP | disclosed |
| EP-2700431-A1 | Plant extracts for modulating TRPV1 function | AnalytiCon Discovery GmbH (DE) | 2014-02-26 | — | — | EP | disclosed |
| EP-2654665-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012083906-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) | 2012-06-28 | — | — | WO | disclosed |
| EP-1718270-A1 | USE OF (2-HYDROXYPHENYL) ALCOHOLS, AND COSMETIC OR THERAPEUTIC FORMULATIONS CONTAINING SAID COMPOUNDS | Symrise GmbH & Co. KG (DE) | 2006-11-08 | — | — | EP | disclosed |
| WO-2005079743-A1 | USE OF (2-HYDROXYPHENYL) ALCOHOLS, AND COSMETIC OR THERAPEUTIC FORMULATIONS CONTAINING SAID COMPOUNDS | SYMRISE GMBH & CO. KG (DE) | 2005-09-01 | — | — | WO | disclosed |
| EP-0690032-B1 | Coating composition for glass surfaces | GOLDSCHMIDT AG TH (DE) | 1998-01-14 | — | — | EP | disclosed |
| EP-0631774-B1 | Fluid or pasty, storage-stable, W1/0/W2 type multiple emulsion | GOLDSCHMIDT AG TH (DE) | 1997-01-08 | — | — | EP | disclosed |
| EP-0690032-A1 | Couting composition for glass surfaces | Th. Goldschmidt AG (DE) | 1996-01-03 | — | — | EP | disclosed |
| EP-0631774-A1 | Fluid or pasty, storage-stable, W1/0/W2 type multiple emulsion | Th. Goldschmidt AG (DE) | 1995-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140350269-A1 | Acetals Esters Produced from Purified Glycerin for Use and Application as Emollients, Lubricants, Plasticizers, Solvents, Coalescents, Humectant, Polymerization Monomers, Additives to Biofuels | GK, DAGLA, DAGLB | GPR84 2382/4885FFAR1 1654/4885MAPT 813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.